Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 10532106 Bicyclic peptide ligands specific for MT1-MMP
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
October 29, 2015
Date of Patent
January 14, 2020
Patent Application Number
15523266
Patent Citations Received
US Patent 11833211 Methods of suppression and treatment of disease comprising administering bicycle peptide ligands specific for EphA2
0
US Patent 11912792 Bicyclic peptide ligands specific for nectin-4
0
US Patent 11970553 Heterotandem bicyclic peptide complex
0
US Patent 10792368 Bicyclic peptide ligands specific for MT1-MMP
US Patent 11241473 Bicyclic peptide ligands and uses thereof
US Patent 10919937 Bicyclic peptide ligands and uses thereof
US Patent 10994019 Bicyclic peptide-toxin conjugates specific for MT1-MMP
US Patent 11623012 Bicyclic peptide ligands specific for EphA2
US Patent 11672868 Bicyclic peptide ligands specific for MT1-MMP
0
US Patent 11746126 Bicyclic peptide ligands with detectable moieties and uses thereof
•••
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
10532106
Patent Primary Examiner
Julie Ha
Find more entities like US Patent 10532106 Bicyclic peptide ligands specific for MT1-MMP
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE